EME starts evaluating a booster of Moderna's covid vaccine
1 min
The European Medicines Agency (EMA) has today started the evaluation of an application for the uses of a booster dose of Spikevax, Moderna's covid 19 vaccine, to be given at least six months after the second dose in people aged 12 years and older. EMA does not consider the booster to be urgent.
